Measuring health-related quality of life in patients with advanced cancer: A systematic review of self-administered measurement instruments

Janneke van Roij; Heidi Fransen; Lonneke van de Poll-Franse; Myrte Zijlstra; Natasja Raijmakers

doi:10.1007/s11136-018-1809-4

Measuring health-related quality of life in patients with advanced cancer: A systematic review of self-administered measurement instruments

Janneke van Roij^*, Heidi Fransen, Lonneke van de Poll-Franse, Myrte Zijlstra, Natasja Raijmakers

^*Corresponding author for this work

Medical and Clinical Psychology

Research output: Contribution to journal › Review article › peer-review

41 Citations (Scopus)

194 Downloads (Pure)

Abstract

Patient-reported outcome measures (PROMs) are becoming increasingly important in clinical practice. The implementation of PROMS in routine practice is challenging because information regarding psychometric quality of measurement instruments is fragmented and standardization is lacking. The aim of this study is to evaluate the quality of self-administered HRQoL measurement instruments for use in patients with advanced cancer in clinical practice.

A systematic literature search was performed in PubMed, Embase, PsycINFO, and CINAHL to identify studies concerning self-administered HRQoL measurement instruments in patients with advanced cancer between January 1990 and September 2016. Quality of the measurement instruments was assessed by predefined criteria derived from the COSMIN checklist.

Sixty-nine articles relating to 39 measurement instruments met the inclusion criteria. Information regarding important measurement properties was often incomplete. None of the instruments performed sufficient on all measurement properties. Considering available information, the EORTC QLQ-C15-PAL appeared to have adequate psychometric properties, together with the EORTC QLQ-BM22.

Many of the existing HRQoL measurement instruments have not yet been evaluated in an adequate manner. Validation of self-administered HRQoL measurement instruments is an ongoing development and should be prioritized. This review contributes to improved clarity regarding the availability and quality of HRQoL measurement instruments for patients with advanced cancer and supports health care professionals in an adequate selection of suitable PROMs in clinical practice.

Original language	English
Pages (from-to)	1937-1955
Journal	Quality of Life Research
Volume	27
Issue number	8
DOIs	https://doi.org/10.1007/s11136-018-1809-4
Publication status	Published - 2018

Keywords

Quality of Life
Medical oncology
Palliative care
Validation studies
Patient-reported outcomes
SYMPTOM ASSESSMENT SCALE
CLINICALLY IMPORTANT DIFFERENCES
RANDOMIZED CONTROLLED-TRIAL
PALLIATIVE CARE POPULATION
REPORTED OUTCOME MEASURES
CELL LUNG-CANCER
BONE METASTASES
EORTC QLQ-BM22
QUESTIONNAIRE QLQ-C30
EUROPEAN-ORGANIZATION

Access to Document

10.1007/s11136-018-1809-4

MCP Poll Franse measuring health related QoLR 2018Final published version, 1.01 MB

Cite this

@article{3db2a591d09b45ec9a0894add54abcce,

title = "Measuring health-related quality of life in patients with advanced cancer: A systematic review of self-administered measurement instruments",

abstract = "Patient-reported outcome measures (PROMs) are becoming increasingly important in clinical practice. The implementation of PROMS in routine practice is challenging because information regarding psychometric quality of measurement instruments is fragmented and standardization is lacking. The aim of this study is to evaluate the quality of self-administered HRQoL measurement instruments for use in patients with advanced cancer in clinical practice.A systematic literature search was performed in PubMed, Embase, PsycINFO, and CINAHL to identify studies concerning self-administered HRQoL measurement instruments in patients with advanced cancer between January 1990 and September 2016. Quality of the measurement instruments was assessed by predefined criteria derived from the COSMIN checklist.Sixty-nine articles relating to 39 measurement instruments met the inclusion criteria. Information regarding important measurement properties was often incomplete. None of the instruments performed sufficient on all measurement properties. Considering available information, the EORTC QLQ-C15-PAL appeared to have adequate psychometric properties, together with the EORTC QLQ-BM22.Many of the existing HRQoL measurement instruments have not yet been evaluated in an adequate manner. Validation of self-administered HRQoL measurement instruments is an ongoing development and should be prioritized. This review contributes to improved clarity regarding the availability and quality of HRQoL measurement instruments for patients with advanced cancer and supports health care professionals in an adequate selection of suitable PROMs in clinical practice.",

keywords = "Quality of Life, Medical oncology, Palliative care, Validation studies, Patient-reported outcomes, SYMPTOM ASSESSMENT SCALE, CLINICALLY IMPORTANT DIFFERENCES, RANDOMIZED CONTROLLED-TRIAL, PALLIATIVE CARE POPULATION, REPORTED OUTCOME MEASURES, CELL LUNG-CANCER, BONE METASTASES, EORTC QLQ-BM22, QUESTIONNAIRE QLQ-C30, EUROPEAN-ORGANIZATION",

author = "{van Roij}, Janneke and Heidi Fransen and {van de Poll-Franse}, Lonneke and Myrte Zijlstra and Natasja Raijmakers",

year = "2018",

doi = "10.1007/s11136-018-1809-4",

language = "English",

volume = "27",

pages = "1937--1955",

journal = "Quality of Life Research",

issn = "0962-9343",

publisher = "Springer Netherlands",

number = "8",

}

TY - JOUR

T1 - Measuring health-related quality of life in patients with advanced cancer

T2 - A systematic review of self-administered measurement instruments

AU - van Roij, Janneke

AU - Fransen, Heidi

AU - van de Poll-Franse, Lonneke

AU - Zijlstra, Myrte

AU - Raijmakers, Natasja

PY - 2018

Y1 - 2018

N2 - Patient-reported outcome measures (PROMs) are becoming increasingly important in clinical practice. The implementation of PROMS in routine practice is challenging because information regarding psychometric quality of measurement instruments is fragmented and standardization is lacking. The aim of this study is to evaluate the quality of self-administered HRQoL measurement instruments for use in patients with advanced cancer in clinical practice.A systematic literature search was performed in PubMed, Embase, PsycINFO, and CINAHL to identify studies concerning self-administered HRQoL measurement instruments in patients with advanced cancer between January 1990 and September 2016. Quality of the measurement instruments was assessed by predefined criteria derived from the COSMIN checklist.Sixty-nine articles relating to 39 measurement instruments met the inclusion criteria. Information regarding important measurement properties was often incomplete. None of the instruments performed sufficient on all measurement properties. Considering available information, the EORTC QLQ-C15-PAL appeared to have adequate psychometric properties, together with the EORTC QLQ-BM22.Many of the existing HRQoL measurement instruments have not yet been evaluated in an adequate manner. Validation of self-administered HRQoL measurement instruments is an ongoing development and should be prioritized. This review contributes to improved clarity regarding the availability and quality of HRQoL measurement instruments for patients with advanced cancer and supports health care professionals in an adequate selection of suitable PROMs in clinical practice.

AB - Patient-reported outcome measures (PROMs) are becoming increasingly important in clinical practice. The implementation of PROMS in routine practice is challenging because information regarding psychometric quality of measurement instruments is fragmented and standardization is lacking. The aim of this study is to evaluate the quality of self-administered HRQoL measurement instruments for use in patients with advanced cancer in clinical practice.A systematic literature search was performed in PubMed, Embase, PsycINFO, and CINAHL to identify studies concerning self-administered HRQoL measurement instruments in patients with advanced cancer between January 1990 and September 2016. Quality of the measurement instruments was assessed by predefined criteria derived from the COSMIN checklist.Sixty-nine articles relating to 39 measurement instruments met the inclusion criteria. Information regarding important measurement properties was often incomplete. None of the instruments performed sufficient on all measurement properties. Considering available information, the EORTC QLQ-C15-PAL appeared to have adequate psychometric properties, together with the EORTC QLQ-BM22.Many of the existing HRQoL measurement instruments have not yet been evaluated in an adequate manner. Validation of self-administered HRQoL measurement instruments is an ongoing development and should be prioritized. This review contributes to improved clarity regarding the availability and quality of HRQoL measurement instruments for patients with advanced cancer and supports health care professionals in an adequate selection of suitable PROMs in clinical practice.

KW - Quality of Life

KW - Medical oncology

KW - Palliative care

KW - Validation studies

KW - Patient-reported outcomes

KW - SYMPTOM ASSESSMENT SCALE

KW - CLINICALLY IMPORTANT DIFFERENCES

KW - RANDOMIZED CONTROLLED-TRIAL

KW - PALLIATIVE CARE POPULATION

KW - REPORTED OUTCOME MEASURES

KW - CELL LUNG-CANCER

KW - BONE METASTASES

KW - EORTC QLQ-BM22

KW - QUESTIONNAIRE QLQ-C30

KW - EUROPEAN-ORGANIZATION

U2 - 10.1007/s11136-018-1809-4

DO - 10.1007/s11136-018-1809-4

M3 - Review article

SN - 0962-9343

VL - 27

SP - 1937

EP - 1955

JO - Quality of Life Research

JF - Quality of Life Research

IS - 8

ER -

Measuring health-related quality of life in patients with advanced cancer: A systematic review of self-administered measurement instruments

Abstract

Keywords

Access to Document

Fingerprint

Cite this